miR‑486 acts as an oncogene and potential prognostic biomarker in renal cell carcinoma

  • Authors:
    • Chengwen Sun
    • Caihong Sun
    • Yibin Zhou
    • Ganglong Yang
    • Guang Li
    • Congming Xiang
    • Xiqi Ding
    • Jian Sun
  • View Affiliations

  • Published online on: October 25, 2019     https://doi.org/10.3892/mmr.2019.10769
  • Pages: 5208-5215
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

MicroRNAs (miRNAs) are well established key players in tumorigenesis. Their emergence as potential diagnostic and prognostic biomarkers for cancer has demonstrated the importance of miRNAs in cancer biology. Although miR‑486 is implicated in many types of cancer, its role in renal cell carcinoma (RCC) remains undetermined. In the present study, real‑time quantitative PCR (qPCR), wound scratch assay, cell proliferation assay, Transwell migration assay and flow cytometry were utilized to detect the miR‑486 transcript and its role in proliferation, migration and apoptosis in RCC. The relationship between miR‑486 expression and clinicopathological variables or overall survival was analyzed using 96 formalin‑fixed paraffin‑embedded (FFPE) RCC samples. The results of the present study revealed significant upregulation of miR‑486 in RCC tissues and cell lines. Moreover, ectopic expression of miR‑486 promoted cell proliferation, mobility and inhibited apoptosis in 786‑O and ACHN cell lines. In addition, the Cox proportional hazard regression analysis revealed that patients with low expression of miR‑486 exhibited a markedly longer overall survival in the univariate and multivariate analyses. In conclusion, our findings indicate that miR‑486 may serve as a novel prognostic biomarker but may also be applied as a new therapeutic approach for the treatment of RCC.
View Figures
View References

Related Articles

Journal Cover

December-2019
Volume 20 Issue 6

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Sun C, Sun C, Zhou Y, Yang G, Li G, Xiang C, Ding X and Sun J: miR‑486 acts as an oncogene and potential prognostic biomarker in renal cell carcinoma. Mol Med Rep 20: 5208-5215, 2019
APA
Sun, C., Sun, C., Zhou, Y., Yang, G., Li, G., Xiang, C. ... Sun, J. (2019). miR‑486 acts as an oncogene and potential prognostic biomarker in renal cell carcinoma. Molecular Medicine Reports, 20, 5208-5215. https://doi.org/10.3892/mmr.2019.10769
MLA
Sun, C., Sun, C., Zhou, Y., Yang, G., Li, G., Xiang, C., Ding, X., Sun, J."miR‑486 acts as an oncogene and potential prognostic biomarker in renal cell carcinoma". Molecular Medicine Reports 20.6 (2019): 5208-5215.
Chicago
Sun, C., Sun, C., Zhou, Y., Yang, G., Li, G., Xiang, C., Ding, X., Sun, J."miR‑486 acts as an oncogene and potential prognostic biomarker in renal cell carcinoma". Molecular Medicine Reports 20, no. 6 (2019): 5208-5215. https://doi.org/10.3892/mmr.2019.10769